Unveiling 5 Analyst Insights On IDEAYA Biosciences
Unveiling 5 Analyst Insights On IDEAYA Biosciences
公佈關於IDEAYA Biosciences的5種分析見解
In the preceding three months, 5 analysts have released ratings for IDEAYA Biosciences (NASDAQ:IDYA), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師發佈了IDEAYA Biosciences（納斯達克股票代碼：IDYA）的評級，提出了從看漲到看跌的各種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $55.4, a high estimate of $60.00, and a low estimate of $52.00. This current average has increased by 24.02% from the previous average price target of $44.67.
分析師分析的12個月目標股價提供了見解，平均目標價爲55.4美元，最高估計爲60.00美元，低估值爲52.00美元。目前的平均價格較之前的平均目標價44.67美元上漲了24.02％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
The analysis of recent analyst actions sheds light on...
對分析師近期行爲的...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。